文献速递肺栓塞与肺血管病

肺动脉楔压升高对球囊肺动脉成形术治疗慢性血栓栓塞性肺动脉高压安全性与疗效的影响

Impact of Elevated Pulmonary Arterial Wedge Pressure on Safety and Efficacy of Balloon Pulmonary Angioplasty in the Treatment of Chronic Thromboembolic Pulmonary Hypertension.
PubMed 文献 · Chest · 2025-10-19

该回顾性研究纳入170例接受球囊肺动脉成形术(BPA)治疗的慢性血栓栓塞性肺动脉高压(CTEPH)患者,比较肺动脉楔压(PAWP)正常与升高两组。PAWP升高者占13.5%,其血流动力学和功能获益较小,但总体生存率和不良事件率无显著差异。提示PAWP升高不影响BPA的安全性及长期生存,但临床获益更有限。

要点

  • PAWP升高者占13.5%,常合并左心功能不全及更多合并症。
  • PAWP升高组BPA术后平均肺动脉压下降更小、肺动脉顺应性和6分钟步行距离改善更少。
  • 两组总体生存率和不良事件率无显著差异,BPA仍可用于PAWP升高患者。

核心结论

  • PAWP升高与BPA术后血流动力学和功能获益减少相关,但不影响手术安全性或长期生存。

研究设计与样本

  • 回顾性分析170例接受BPA治疗的CTEPH患者,按PAWP正常或升高分组比较。

主要发现

  • PAWP升高者占13.5%,年龄更大、BMI更高、基线肌钙蛋白更高且合并症负担更重。
  • PAWP升高组平均肺动脉压下降更小(P = .026)。
  • PAWP升高组肺动脉顺应性改善更低(P = .002)。
  • PAWP升高组6分钟步行距离改善更低(P = .011)。
  • 两组总体生存率和不良事件率无显著差异。

临床怎么用

  • 对PAWP升高的CTEPH患者,BPA仍可安全实施,但应预期血流动力学和功能获益较有限。

局限性

  • 回顾性研究设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare condition caused by thromboembolic occlusions of the pulmonary arteries and characterized by elevated pulmonary pressure, vascular remodelling, and right ventricular overload, which can be treated effectively with balloon pulmonary angioplasty (BPA). The study aimed to evaluate whether elevated pulmonary arterial wedge pressure (PAWP), associated with left ventricular dysfunction, influences the effectiveness and safety of BPA treatment. RESEARCH QUESTION: Does elevated PAWP affect the effectiveness and safety of BPA in patients with CTEPH? STUDY DESIGN AND METHODS: A retrospective analysis was conducted of 170 patients with CTEPH treated with BPA. Patients were classified into 2 groups: those with normal PAWP and those with elevated PAWP. Hemodynamic parameters, exercise capacity, treatment outcomes, and safety profiles were compared between the groups. Multivariate analysis of overall survival also was performed. RESULTS: Elevated PAWP was present in 13.5% of patients. The elevated PAWP group was older, had a higher BMI, had higher elevated baseline troponin levels, and had a greater burden of comorbidities-including diabetes, atrial fibrillation, deep vein thrombosis, and chronic kidney disease-than patients with normal PAWP. After treatment, patients with elevated PAWP exhibited significantly smaller reduction in mean pulmonary artery pressure (P = .026) and lower improvement in pulmonary arterial compliance (P = .002) and 6-minute walk distance (P = .011) compared with those with normal PAWP. No significant differences were found in overall survival or adverse event rates observed between the groups. INTERPRETATION: Elevated PAWP, likely reflecting coexisting left-sided heart dysfunction, was associated with reduced hemodynamic and functional benefits resulting from BPA in patients with CTEPH. Nevertheless, it did not compromise procedural safety or long-term survival, suggesting that BPA remains a viable option in this subgroup, albeit with more modest clinical gains.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Szwed P, Kurzyna P, Banaszkiewicz M, et al. Impact of Elevated Pulmonary Arterial Wedge Pressure on Safety and Efficacy of Balloon Pulmonary Angioplasty in the Treatment of Chronic Thromboembolic Pulmonary Hypertension. Chest. 2025. PMID: 41115606. doi:10.1016/j.chest.2025.10.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。